TrialBone marrow transplantation2018

High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma.

Sonata Jodele et al.PubMed ↗Publisher ↗

No numbers read from the abstract.